Cost-Effectiveness Analysis: Risk Stratification of Nonalcoholic Fatty Liver Disease (NAFLD) by the Primary Care Physician Using the NAFLD Fibrosis Score

Understanding and Reducing Ceruloplasmin Overuse with a Decision Support Intervention for Liver Disease Evaluation

(2016) Elliot B. Tapper et al.   AMERICAN JOURNAL OF MEDICINE

Cost-Effective Evaluation of Nonalcoholic Fatty Liver Disease With NAFLD Fibrosis Score and Vibration Controlled Transient Elastography

(2015) Elliot B Tapper et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

FibroScan (Vibration-Controlled Transient Elastography): Where Does It Stand in the United States Practice

(2015) Elliot B. Tapper et al.   Clinical Gastroenterology and Hepatology

Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies

(2015) Siddharth Singh et al.   Clinical Gastroenterology and Hepatology

Vibration-controlled transient elastography

(2015) Elliot B. Tapper et al.   CURRENT OPINION IN GASTROENTEROLOGY

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

(2015) Paul Angulo et al.   GASTROENTEROLOGY

The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease

(2015) Salvatore Petta et al.   HEPATOLOGY

Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

(2015) Mattias Ekstedt et al.   HEPATOLOGY

Trends in Outpatient Resource Utilizations and Outcomes for Medicare Beneficiaries With Nonalcoholic Fatty Liver Disease

(2015) Zobair M. Younossi et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Controlled attenuation parameter (CAP) for the diagnosis of steatosis: A prospective study of 5323 examinations

(2014) Victor de Lédinghen et al.   JOURNAL OF HEPATOLOGY

The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease

(2014) Salvatore Petta et al.   LIVER INTERNATIONAL

Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold

(2014) Peter J. Neumann et al.   NEW ENGLAND JOURNAL OF MEDICINE

Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis

(2014) Amit G. Singal et al.   PLOS MEDICINE

Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease - the role of transient elastography and plasma cytokeratin-18 fragments

(2013) R. Kwok et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Prevalence of Nonalcoholic Fatty Liver Disease in the United States: The Third National Health and Nutrition Examination Survey, 1988–1994

(2013) Mariana Lazo et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

The Overuse of Serum Ceruloplasmin Measurement

(2013) Elliot B. Tapper et al.   AMERICAN JOURNAL OF MEDICINE

Review article: the diagnosis of non-alcoholic fatty liver disease - availability and accuracy of non-invasive methods

(2012) D. Festi et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Liver Stiffness Measurement Using XL Probe in Patients With Nonalcoholic Fatty Liver Disease

(2012) Vincent Wai-Sun Wong et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Levels of Alanine Aminotransferase Confound Use of Transient Elastography to Diagnose Fibrosis in Patients With Chronic Hepatitis C Virus Infection

(2012) Elliot B. Tapper et al.   Clinical Gastroenterology and Hepatology

Burden of Gastrointestinal Disease in the United States: 2012 Update

(2012) Anne F. Peery et al.   GASTROENTEROLOGY

The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

(2012) Naga Chalasani et al.   HEPATOLOGY

Management of Nonalcoholic Fatty Liver Disease

(2012) Nezam H. Afdhal   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: Comparison between M and XL probe of FibroScan®

(2011) Victor de Lédinghen et al.   JOURNAL OF HEPATOLOGY

Dropping the Baton: Specialty Referrals in the United States

(2011) ATEEV MEHROTRA et al.   MILBANK QUARTERLY

Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis

(2010) J. K. Dowman et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

(2010) Arun J. Sanyal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis

(2009) Kittichai Promrat et al.   HEPATOLOGY